Lonza Invites Visitors to Discover Innovative Integrated Concepts for Human and Pet Nutrition at SupplySide East 2019
Morristown, NJ (USA), 3 April 2019 – Lonza will bring its expanded portfolio of innovative dosage form solutions and technologies to support the evolving human and pet nutrition spaces to this year’s SupplySide East at Secaucus, NJ (USA). Following the acquisition of Capsugel in 2017 and its subsequent advancement of consumer-focused delivery technologies, Lonza is the official capsule sponsor of the show.
At booth F128, Lonza’s Consumer Health & Nutrition team will also showcase its integrated capabilities through its range of science-backed ingredients and market-ready concepts for joint health, sports nutrition, healthy aging and pet nutrition.
New consumer insights into the dietary supplements market, commissioned by Lonza, identified that capsules are the leading dosage form for consumers in the United States, primarily due to their convenience. Consumers are, however, also increasingly seeking “unquestionable safety” and “scientific or clinical proof of efficacy” when purchasing supplements, meaning science-backed solutions are more important than ever before.1
The insights also revealed that 78% of respondents preferred products that are derived from natural sources. A fast-growing trend, naturally-derived supplement choices have seen a significant increase in consumer preference since 20132. This surge is reflective of the growing demand for plant-based, natural, vegetarian and vegan products.
At SupplySide East, Lonza will highlight its expanding portfolio of science-backed, clean-label supplement ingredient and dosage form solutions to help manufacturers develop or reformulate products to meet consumer needs.
Dosage form matters
Visitors to booth F128 will also have the opportunity to discover Lonza’s proprietary Licaps® technology. Licaps® liquid-filled hard capsules help to deliver functional improvements in bioavailability enhancement, taste and odor masking, combination product development and delayed release. Also on display will be Lonza’s Vcaps® Plus Purple Carrot capsule, the latest addition to its clean-label food-colored capsules. With its shell consisting of hypromellose (HPMC) and water only, the Vcaps® Plus Purple Carrot capsule is colored using the extract of purple carrots and allows manufacturers and brand owners to add color to capsules while supporting a clean-label positioning.
Delegates can also find out more about Lonza’s non-GMO certified DRcaps™ modified release HPMC capsules, which are designed to protect ingredients like probiotics from stomach acidity and moisture.
Lonza’s expanding ingredient offering, including the new Oceanix™ performance nutrition brand, will be a focal point at the show. Oceanix™ is a unique marine phytoplankton ingredient that is sustainably sourced from the ocean. The clean-label Oceanix™ brand offers potential benefits for peak physical performance and recovery in a small, concentrated dose of 25mg/day.
Lonza will also showcase its market-leading concepts for joint health, including its patented UC-II® undenatured type II collagen, which is clinically shown to support joint health and mobility by improving joint comfort and flexibility. The scientifically backed ResistAid® ingredient, offering year-round immune benefits, will also be highlighted on-stand.
In addition to its concepts for joint health and performance nutrition, Lonza will showcase product concepts to support healthy aging and pet nutrition. With consumers’ choices in pet nutrition becoming more closely aligned with their own dietary preferences, Lonza’s UC-II® ingredient offers significant potential in supporting the health and wellbeing of pets, and the team will be highlighting its expanded applications in this space. Lonza was also recently granted U.S. Patent 10,016,382 for its Carniking® L-Carnitine ingredient for active dogs and working animals, which confirmed evidence of the ingredient’s beneficial impact on performance and recovery.
1NMI SORD Proprietary Report for Lonza Consumer Health & Nutrition – US – 2,004 participants on-line, 2018.
2NMI SORD Proprietary Report for Lonza Consumer Health & Nutrition – US – 2,004 participants on-line, 2018.